1[1]Goussard J, Lechevrel C, Roussel G, et al. Immunoradiometric assay of pS2 protein in breast cancer cytosols. Clin. Chem, 1991, 37(10): 1759～1762
2[2]Hahnel E, Robbins P, Harvey J, et al. Expression of the pS2gene in breast tissues assessed by pS2-mRNA analysis and pS2-protein radioimmunoassay. Breast Cancer Res Treat,1992, 24(1): 71～74
3[3]Detre S, King N, Salter J et al. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer. J Clin Pathol, 1994, 47(3): 240～244
4[4]Tong D, Schneeberger C, Czerwenka K, et al. Messager RNA determination of estrogen receptor, progesterone receptor, pS2,and plasminagen activation inhibior-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Clin Cancer Res, 1999, 5(6): 1497～1502
5[5]Henry JA, Piggott NH, Mallick UK, et al. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer, 1991,63(4): 615～622
6[6]Looi LM, Azura WW, Cheah PL, et al. pS2 expression in infiltrating ductal carcinoma of the breast correlates with oestrogen receptor positivity but not with histological grade and lymph node staris. Pathology, 2001, 33(3): 283～286
7[7]Rio MC, Belloc JP, Gairard B, et al. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Proc Nall Acad Sci. USA, 1987, 87:9243～9247
8[8]Henry JA, Nicholson S, Hennessy C, et al. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer:relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer, 1990, 61(1): 32～38
9[9]Foekens JA, Rio MC, Seguin P, et al. Prediction of relapse and survival in breast cancer patients by pS2 protein starus.Cancer Res, 1990, 50(13): 3832～3837
10[10]Schwarchtz LH, Koerner FC, Edgerton SM, et al. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res, 1991, 51(2): 624～628
同被引文献15
1[1]Kelleher M,Miles D.The adjuvant treatment of breast cancer.Int J Clin Pract,2003,57:195-199.
2[3]Thompson AM,Hawkins R A,Elton R A,et al.PS2 is an independent factor of good prognosis in primary breast cancer.Br J Cancer,1993,68:93-96.
3[4]Masiakowski P,Breathnach R,Bloch J,et al.Cloning of cDNA sequences of hormone regulated genes from the MCF-7 human breast cancer cell line.Nucleic Acids Res,1982,10:7895-7903.
4[7]Foekens J A,Bin M C,Seguin P,et al.Prediction of rehpse and survival in breast cancer patients by PS2 protein status.Cancer Res,1990,50:3832-3837.
5[8]Krieger N,Van den Eeden SK,Zava D,et al.Race/ethnicity,social class,and prevalence of breast cancer prognostic biomarkers:a study of white,black,and Asian women in the San-Francisco bay area.Ethn Dis,1997,7:137-149.
6Schwarchtz LH, Koerner FC, Edgerton SM,et al. ps2 expres sion and response to hormonal therapy in patients with advanced breast cancer[J]. Cancer Res, 1991,51(2) :624-628.
7Kelleher M, Miles D. The adjuvant treatment of breast cancer[J]. Int J Clin Pract, 2003, 57(3): 195-199.
8Thompson AM, Hawkins RS, Elton RA, et al. PS2 is an independent factor of good prognosis in primary breast cancer[J]. Br J Cancer, 1993, 68( 1 ) :93-96.
9Gion M, Mione R, Pappagallo GL, et al. PS2 in breast cancer; alternative or comptementary tool to stersid recept or status? Evaluation of 446 cases[J]. Br J Cancer, 1993,68(2) :374-379.
10Detre S, King N, Salter J, et al. Immunohistochemical and biochemical analysis of the oestrogen receptor and progesterone receptor in breast cancer [J]. J Clin Pathol,1994,47(3) :240-244.
